Enzymatica AB (publ) (FRA:EN9)
Germany · Delayed Price · Currency is EUR 0.1430
-0.0040 (-2.72%)
At close: Nov 28, 2025
Enzymatica AB Company Description
Enzymatica AB (publ), a life science company, develops and sells medical devices for infection-related diseases.
The company’s product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that can cause cold and flu symptoms.
It also provides enzyme formulations for skin care. The company was incorporated in 2007 and is headquartered in Lund, Sweden.
Enzymatica AB (publ)
| Country | Sweden |
| Founded | 2007 |
| Industry | Pharmaceutical Preparations |
| Employees | 21 |
| CEO | Claus Egstrand |
Contact Details
Address: Ideon Science Park Lund, 223 70 Sweden | |
| Phone | 46 4 62 86 31 00 |
| Website | enzymatica.com |
Stock Details
| Ticker Symbol | EN9 |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Claus Egstrand | Chief Executive Officer |
| Therese Filmersson | Chief Financial Officer |
| Claes Molin | Chief Operating Officer |